Towards Healthcare

Published Market Research Reports

Your marketplace is evolving, your competitors are readjusting – but instead of reacting you can proact

February 26, 2024

Glutamine Market Size Envisioned at USD 175.27 Billion by 2033

  • Status : Published
  • No. of Pages: 150+
  • Category : Biotechnology

Insight Highlights: Glutamine's getting bigger! The market, valued at USD 130.94 million in 2023. It is projected to muscle its way to USD 175.27 billion by 2033. It is estimated to grow at 3.2% CAGR over the forecast period. L-glutamine leads ...

February 22, 2024

Thermostable Vaccine Market Trends, Growth, Share and Outlook

  • Status : Published
  • No. of Pages: 150+
  • Category : Biotechnology

Insight Highlights: Thermostable vaccines present a potential market that can replace the global vaccine market by at least 20% in the next decade. In 2021, WHO reported 94 firms distributing vaccines in Member States. China, with 23, and India,...

February 19, 2024

RNAi Therapeutics Market Size Envisioned at USD 4.28 Billion by 2033

  • Status : Published
  • No. of Pages: 150+
  • Category : Biotechnology

Insight Highlights: The RNAi therapeutics market, once a specialized niche, is exploding! In 2023, it hit USD 1.11 billion. It is projected to soar at a remarkable 14.9% CAGR over the forecast period. RNAi therapeutics to reach a staggering USD ...

February 15, 2024

Advanced Drug Delivery Market Size Envisioned at USD 375.86 Billion by 2033

  • Status : Published
  • No. of Pages: 150+
  • Category : Biotechnology

Insight Highlights: Advanced drug delivery thrived in 2023, reaching a market size of USD 234.84 billion. Projections estimate to reach USD 375.86 billion market size by 2033. Market is growing at a CAGR of 4.6% for the forecasted year 2023 - 20...

February 08, 2024

Biologics Market Size Envisioned at USD 845.78 Billion by 2033

  • Status : Published
  • No. of Pages: 150+
  • Category : Biotechnology

Report Highlights The biologics market size ballooned to a staggering USD 419.07 billion in 2023. It is anticipated to attain USD 845.78 billion by 2033. It is expected to register 7.6% of CAGR by 2032. Monoclonal antibodies led the market in 2...

June 15, 2023

Genomics Market Size Envisioned at USD 127.16 Billion by 2032

  • Status : Published
  • No. of Pages: 150
  • Category : Biotechnology

The global genomics market size surpassed USD 28.9 billion in 2022 and is estimated to reach around USD 127.16 billion by 2032, expanding at a CAGR of 16.1% from 2023 to 2032, as a result of rising technology advancements and increasing demand for pe...

May 31, 2023

Cell and Gene Therapy Market Size Envisioned at USD 117.1 Billion by 2032

  • Status : Published
  • No. of Pages: 150
  • Category : Biotechnology

The global cell and gene therapy market size is estimated to grow from USD 14.2 billion in 2022 at 24% CAGR (2023-2032) to reach an estimated  USD 117.1 billion by 2032, as a result of rising clinical trials and the increasing number of product ...

May 30, 2023

Cell Therapy Manufacturing Market Size Envisioned at USD 16.40 Billion by 2032

  • Status : Published
  • No. of Pages: 150
  • Category : Biotechnology

The global cell therapy manufacturing market is estimated to grow from USD 3.92 billion in 2022 at 16% CAGR (2023-2032) to reach an estimated USD 16.40 billion by 2032. Nearly all cancer diagnoses, accounting for 90% of cases, require cell therapi...

May 24, 2023

Artificial Intelligence (AI) in Genomics Market Size Envisioned at USD 7,365.59 Million by 2032

  • Status : Published
  • No. of Pages: 150
  • Category : Biotechnology

The global AI in genomics market size is estimated to grow from USD 397.64 million in 2022 at 23.6% CAGR (2023-2032) to reach an estimated  USD 7,365.59 million by 2032, as a result of growing cross-industry collaborations and increasing R&D...

May 09, 2023

Biosimilars Market Size Envisioned at USD 1,26,019.67 Million by 2032

  • Status : Published
  • No. of Pages: 150
  • Category : Biotechnology

The global biosimilar market size is estimated to grow from USD 25,125.36 million in 2022 at 17.6% CAGR (2023-2032) to reach an estimated  USD 1,26,019.67 million by 2032, as a result of the rising prevalence of cancer, and cost effectivity of b...